Detalhe da pesquisa
1.
Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience. / [Artículo traducido]Eficacia y seguridad de dupilumab para el tratamiento de la dermatitis atópica grave en la práctica clínica: experiencia en un centro terciario.
Actas Dermosifiliogr
; 115(2): T150-T158, 2024 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38048951
2.
Efficacy and Safety of Dupilumab for the Treatment of Severe Atopic Dermatitis in Clinical Practice: A Single Center Experience.
Actas Dermosifiliogr
; 115(2): 150-158, 2024 Feb.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-37858860
3.
Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.
J Eur Acad Dermatol Venereol
; 2023 Dec 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153843
4.
Performance of Coronary Artery Calcium Testing in Patients With Severe Psoriasis: Risk Assessment and Reclassification Potential in a Low Cardiovascular Risk Population.
Actas Dermosifiliogr
; 113(8): 773-780, 2022 Sep.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-35523308
5.
Changes in the Prevalence of Human Papillomavirus Genotypes in Genital Warts Since the Introduction of Prophylactic Vaccines. / Modificación de la prevalencia de genotipos del virus del papiloma humano en los condilomas acuminados tras la instauración de la vacuna profiláctica.
Actas Dermosifiliogr
; 113(9): 874-880, 2022 Oct.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-35688211
6.
Definition of minimal disease activity in psoriasis.
J Eur Acad Dermatol Venereol
; 35(2): 422-430, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32367536
7.
Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasis.
J Eur Acad Dermatol Venereol
; 33(7): 1214-1223, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31037770
8.
Comparison of phenotype, comorbidities, therapy and adverse events between psoriatic patients with and without psoriatic arthritis. Biobadaderm registry.
J Eur Acad Dermatol Venereol
; 31(6): 1021-1028, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28252811
9.
Adverse events associated with discontinuation of the biologics/classic systemic treatments for moderate-to-severe plaque psoriasis: data from the Spanish Biologics Registry, Biobadaderm.
J Eur Acad Dermatol Venereol
; 31(10): 1700-1708, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28485816
10.
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm Registry. / Manejo de los tratamientos biológicos en pacientes con psoriasis moderada-grave sometidos a intervenciones quirúrgicas en el registro español Biobadaderm.
Actas Dermosifiliogr
; 108(1): 52-58, 2017.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-27658689
11.
Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology.
J Eur Acad Dermatol Venereol
; 30 Suppl 2: 1-18, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26812550
12.
Survival of classic and biological systemic drugs in psoriasis: results of the BIOBADADERM registry and critical analysis.
J Eur Acad Dermatol Venereol
; 30(11): 1942-1950, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27329511
13.
Methotrexate in Moderate to Severe Psoriasis: Review of the Literature and Expert Recommendations.
Actas Dermosifiliogr
; 107(3): 194-206, 2016 Apr.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-26614486
14.
Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasis.
Pharmacogenomics J
; 15(4): 322-5, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25403996
15.
Photoallergic contact dermatitis to topical ketoconazole.
J Eur Acad Dermatol Venereol
; 34(9): e499-e501, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32249483
16.
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registry.
J Eur Acad Dermatol Venereol
; 29(5): 858-64, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25185962
17.
Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5-year observational study of clinical practice: 2008-2013 results of the Biobadaderm registry.
J Eur Acad Dermatol Venereol
; 29(1): 156-63, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24684267
18.
Immune-mediated inflammatory diseases and other comorbidities in patients with psoriasis: baseline characteristics of patients in the AQUILES study.
Actas Dermosifiliogr
; 106(1): 35-43, 2015.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-25091923
19.
Biosimilars in Dermatology: Current Situation (Part II).
Actas Dermosifiliogr
; 106(7): 550-4, 2015 Sep.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-26049964
20.
Biosimilars in Dermatology: Current Situation (Part I).
Actas Dermosifiliogr
; 106(7): 545-9, 2015 Sep.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-25987472